Skip to main content

Table 3 Outcomes in the overall population with ventilator acquired pneumonia

From: Multidrug-resistant pathogens and ventilator-associated pneumonia in critically ill COVID-19 and non-COVID-19 patients: a prospective observational monocentric comparative study

 

Study group

 

Characteristic

Overall, N = 2031

NON-COVID-19, N = 781

COVID-19, N = 1251

p-value2

ICU length of stay, days

26 (16, 39)

26 (14, 49)

26 (18, 32)

0.7

Hospital length of stay, days

30 (22, 60)

61 (29, 90)

26 (19, 34)

< 0.001

Duration of MV, days

19 (11, 31)

20 (9, 43)

18 (13, 25)

0.3

Death in ICU

114 (56%)

26 (33%)

88 (71%)

< 0.001

Death in hospital

125 (62%)

33 (43%)

92 (74%)

< 0.001

  1. 1n (%); Median (IQR), 2Pearson’s Chi-squared test; Fisher’s exact test, Wilcoxon rank sum test
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us